1. U.S. Food and Drug Administration. Over-the-Counter (OTC): Nonprescription Drugs. Available at https://www.fda.gov/drugs/how-drugs-are-developed-and-approved/over-counter-otc-nonprescription-drugs. Last accessed August 31, 2025.

2. Lexidrug. Available at https://online.lexi.com. Last accessed August 31, 2025.

3. U.S. Food and Drug Administration. Acetaminophen. Available at https://www.fda.gov/drugs/information-drug-class/acetaminophen. Last accessed August 31, 2025.

4. Daily Med. Available at https://dailymed.nlm.nih.gov/dailymed. Last accessed August 31, 2025.

5. Cooper SA, Beaver WT. A model to evaluate mild analgesics in oral surgery outpatients. Clin Pharmacol Ther. 1976;20(2):241-250.

6. Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. J Am Dent Assoc. 2002;133(7):861-871.

7. Cooper SA, Desjardins PJ. The value of the dental impaction pain model in drug development. Methods Mol Biol. 2010;617:175-190.

8. Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev. 1993;45(1):43-85.

9. Laska EM, Sunshine A, Zighelboim I, et al. Effect of caffeine on acetaminophen analgesia. Clin Pharmacol Ther. 1983;33(4):498-509.

10. Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;(12):CD009281.

11. Abou-Atme YS, Melis M, Zawawi KH. Efficacy and safety of acetaminophen and caffeine for the management of acute dental pain: a systematic review. Saudi Dental J. 2019;31(4):417-423.

12. Mehlisch DR, Sollecito WA, Helfrick JF, et al. Multicenter clinical trial of ibuprofen and acetaminophen in the treatment of postoperative dental pain. J Am Dent Assoc. 1990;121(2):257-263.

13. Weil K, Hooper L, Afzal Z, et al. Paracetamol for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev. 2007;3:CD004487.

14. Skoglund JA, Skjelbred P, Fyllingen G. Analgesic efficacy of acetaminophen 1,000 mg, acetaminophen 2,000 mg, and the combination of acetaminophen 1,000 mg and codeine phosphate 60 mg versus placebo in acute postoperative pain. Pharmacotherapy. 1991;11(5):364-369.

15. Toms L, McQuay HJ, Derry S, Moore RA. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev. 2008;4:CD004602.

16. Cooper SA, Precheur H, Rauch D, Rosenheck A, Ladov M, Engel J. Evaluation of oxycodone and acetaminophen in treatment of postoperative dental pain. Oral Surg Oral Med Oral Pathol. 1980;50(6):496-501.

17. ClinicalTrials.gov. An Effectiveness and Safety Study of Acetaminophen 1,000 mg and Ibuprofen 400 mg in Postoperative Dental Pain. Available at https://clinicaltrials.gov/ct2/show/NCT00240825. Last accessed August 31, 2025.

18. Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal anti-inflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010;110(4):1170-1179.

19. Derry CJ, Derry S, Moore RA. Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain. Cochrane Database Syst Rev. 2013;6:CD010210.

20. Ferraiolo DM, Veitz-Keenan A. Ibuprofen is superior to paracetamol for pain relief following third molar removal. Evid Based Dent. 2014;15(4):106-107.

21. Atkinson HC, Currie J, Moodie J, et al. Combination paracetamol and ibuprofen for pain relief after oral surgery: a dose ranging study. Eur J Clin Pharmacol. 2015;71(5):579-587.

22. Farrell SE. Acetaminophen Toxicity. Available at https://emedicine.medscape.com/article/820200-overview. Last accessed August 31, 2025.

23. U.S. Food and Drug Administration. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use: final monograph. Federal Register. 2010;74(81):19385-19409.

24. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology. 1995;22(3):767-773.

25. Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol. 2015;89(2):193-199.

26. Daly FF, O'Malley GF, Heard K, Bogdan GM, Dart RC. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med. 2004;44(4):393-398.

27. Hersh EV, Lally ET, Moore PA. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray? Curr Med Res Opin. 2005;21(8):1217-1226.

28. Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201-232.

29. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Nat Acad Sci U S A. 2002;99(21):13926-13931.

30. Ohashi N, Kohno T. Analgesic effect of acetaminophen: a review of known and novel mechanisms of action. Front Pharmacol. 2020;11:580289.

31. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA. 1998;279(9):657-662.

32. Gebauer MG, Nyfort-Hansen K, Henschke PJ, Gallus AS. Warfarin and acetaminophen interaction. Pharmacotherapy. 2003;23(1):109-112.

33. Mahe I, Caulin C, Bergmann JF. Does paracetamol potentiate the effects of oral anticoagulants? A literature review. Drug Safety. 2004;27(5):325-333.

34. Hughes GJ, Patel PN, Saxema N. Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy. Pharmacotherapy. 2011;31(6):591-597.

35. Parra D, Beckey NP, Stevens GR. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy. 2007;27(5):675-683.

36. Mahé I, Bertrand N, Drouet L, et al. Paracetamol: a haemorrhagic risk factor in patients on warfarin. Br J Clin Pharmacol. 2005;59(3):371-374.

37. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 25th ed. Hudson, OH: LexiComp, Inc.; 2019-2020.

38. U.S. Food and Drug Administration. Drugs@FDA: FDA Approved Drugs. Available at https://www.accessdata.fda.gov/scripts/cder/daf. Last accessed August 31, 2025.

39. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warning-non-aspirin-nonsteroidal-anti-inflammatory. Last accessed August 31, 2025.

40. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;3:CD001548.

41. Christensen S, Paluch E, Jayawardena S, Daniels S, Meeves S. Analgesic efficacy of a new, immediate-release/extended-release formulation of ibuprofen: results from single- and multiple-dose postsurgical dental pain studies. Clin Pharmacol Drug Dev. 2017;6(3):302-312.

42. Beaver WT. Review of the analgesic efficacy of ibuprofen. Int J Clin Pract Suppl. 2003;(135):13-17.

43. Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother. 2010;44(3):489-506.

44. Doyle G, Jayawardena S, Ashraf E, Cooper SA. Efficacy and tolerability of nonprescription ibuprofen versus celecoxib for dental pain.J Clin Pharmacol. 2002;42(8):912-919.

45. ClinicalTrials.gov. A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain. Available at https://www.clinicaltrials.gov/study/NCT05761574. Last accessed August 31, 2025.

46. Angiolillo DJ, Weisman SM. Clinical pharmacology and cardiovascular safety of naproxen. Am J Cardiovasc Drugs. 2017;17(2):97-107.

47. Wiegand T. Nonsteroidal Anti-Inflammatory Drug (NSAID) Toxicity. Available at https://emedicine.medscape.com/article/816117-overview. Last accessed September 1, 2025.

48. Cooper SA, Reynolds DC, Reynolds B, Hersh EV. Analgesic efficacy and safety of (R)-ketoprofen in postoperative dental pain. J Clin Pharmacol. 1998;38(2 suppl):11S-18S.

49. Akural E, Järvimäki V, Länsineva A, Niinimaa A, Alahuhta S. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1,000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial. Clin Ther. 2009;31(3):560568.

50. Mehlisch DR, Frakes L, Cavaliere MB, Gelman M. Double-blind parallel comparison of single oral doses of ketoprofen, codeine, and placebo in patients with moderate to severe dental pain. J Clin Pharmacol. 1984;24(11-12):486492.

51. Mehlisch DR, Jasper RD, Brown P, Korn SH, McCarroll K, Murakami AA. Comparative study of ibuprofen lysine and acetaminophen in patients with postoperative dental pain. Clin Ther. 1995;17(5):852860.

52. Kim SJ, Seo JT. Selection of analgesics for the management of acute and postoperative dental pain: a mini-review. J Periodontal Implant Sci. 2020;50(2):68-73.

53. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143-150.

54. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an under-recognized public health problem. Arch Intern Med. 2000;160(6):777-784.

55. Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure: relation to activation of the rennin-angiotensin system and hyponatremia. N Engl J Med. 1984;310(6):347-352.

56. Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 1998;158(10):1108-1112.

57. Ungprasert P, Srivali N, Thongprayoon C. Nonsteroidal anti-inflammatory drugs and risk of incident heart failure: a systematic review and meta-analysis of observational studies. Clin Cardiol. 2016;39(2):111-118.

58. Arfé A, Scotti L, Varas-Lorenzo C, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016;354:i4857.

59. Schug SA, Parsons B, Chunming L, Feng X. The safety profile of parecoxib for the treatment of postoperative pain: a pooled analysis of 28 randomized, double-blind, placebo-controlled clinical trials and a review of over 10 years of postauthorization data. J Pain Res. 2017;10:2451-2459.

60. Scott PA, Kingsley GH, Scott DL. Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomized controlled trials. Eur J Heart Fail. 2008;10(11):1102-1107.

61. Huerta C, Varas-Lorenzo C, Castellsague J, García Rodríguez LA. Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart. 2006;92(11):1610-1615.

62. Mukherjee D. Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? Congest Heart Fail. 2008;14(2):75-82.

63. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA Strengthens Warning that Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) can Cause Heart Attacks or Strokes. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warning-non-aspirin-nonsteroidal-anti-inflammatory. Last accessed September 1, 2025.

64. U.S. Food and Drug Administration. Concomitant Use of Ibuprofen and Aspirin: Potential for Attenuation of the Antiplatelet Effect of Aspirin. Available at https://www.fda.gov/media/76636/download. Last accessed September 1, 2025.

65. U.S. Food and Drug Administration. Information about taking Ibuprofen and Aspirin Together. Available at https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-taking-ibuprofen-and-aspirin-together. Last accessed September 1, 2025.

66. Carrasco-Labra A, Polk DE, Urquhart O, et al. Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults. JADA. 2024;155(2):102-117.

67. U.S. Food and Drug Administration. Celebrex. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020998s058lbl.pdf. Last accessed September 1, 2025.

68. National Institute of Dental and Craniofacial Research. Opioids—Information for Dentists. Available at https://www.nidcr.nih.gov/health-info/opioids-information-dentists. Last accessed September 1, 2025.

69. U.S. Food and Drug Administration. FDA's Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain, 2023. Available at https://www.fda.gov/media/173774/download. Last accessed September 1, 2025.

70. U.S. Food and Drug Administration. Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). Available at https://www.fda.gov/drugs/information-drug-class/opioid-analgesic-risk-evaluation-and-mitigation-strategy-rems. Last accessed September 1, 2025.

71. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA Warns About Several Safety Issues with Opioid Pain Medicines; Requires Label Changes. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-several-safety-issues-opioid-pain-medicines-requires. Last accessed September 1, 2025.

72. U.S. Drug Enforcement Administration. Controlled Substances Schedules. Available at https://www.deadiversion.usdoj.gov/schedules/schedules.html. Last accessed September 1, 2025.

73. California Office of the Attorney General. AB 149: New Requirements for Prescription Forms. Available at https://oag.ca.gov/sites/all/files/agweb/pdfs/security-printers/ab-149.pdf. Last accessed September 5, 2022.

74. State of California Department of Consumer Affairs. AB 2789 Bulletin: Prescribing Laws Take Effect January 1, 2022. Available at https://www.dca.ca.gov/licensees/ab2789_bulletin.pdf. Last accessed September 5, 2022.

75. Department of Consumer Affairs, Physician Assistant Board. Rescheduling Hydrocodone Combination Products to Schedule II. Available at https://www.pab.ca.gov/licensees/resch_hydro.shtml. Last accessed September 5, 2022.

76. California Medical Association. Products That Contain Hydrocodone Reclassified to Schedule II. Available at https://www.cmadocs.org/newsroom/news/view/ArticleID/21233/t/Products-that-contain-hydrocodone-reclassified-to-Schedule-II. Last accessed September 5, 2022.

77. RxList. Combunox. Available at https://www.rxlist.com/combunox-side-effects-drug-center.htm. Last accessed September 1, 2025.

78. Van Dyke T, Litkowski LJ, Kiersch TA, Zarringhalam NM, Zheng H, Newman K. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of postoperative pain: a double-blind, placebo- and active-controlled parallel group study. Clin Ther. 2004;26(12):2003-2014.

79. Litkowski LJ, Christenen SE, Adamson DN, Van Dyke T, Han SH, Newman KB. Analgesic efficacy and tolerability of oxycodone 5mg/ibuprofen 400 mg compared to those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Clin Ther. 2005;27(4):418-429.

80. Derry S, Derry CJ, Moore RA. Single dose oral ibuprofen plus oxycodone for acute postoperative pain in adults. Cochrane Database Syst Rev. 2013;6:CD010289.

81. Moroz BT, Ignatov YD, Kalinin VI. Use of tramadol hydrochloride in therapeutic operative dentistry: clinical investigation. Curr Ther Res. 1991;49(3):371-375.

82. Jung YS, Kim DK, Kim MK, et al. Onset of analgesia and analgesic efficacy of tramadol/acetaminophen and codeine/acetaminophen/ibuprofen in acute postoperative pain: a single-center, single-dose, randomized, active-controlled, parallel-group study in a dental surgery pain model. Clin Ther. 2004;26(7):1037-1045.

83. Fricke JR Jr, Karim R, Jordan D, Rosenthal N. A double-blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery. Clin Ther. 2002;24(6):953-968.

84. Medve RA, Wang J, Karim R. Tramadol and acetaminophen tablets for dental pain. Anesth Prog. 2001;48(3):79-81.

85. Gönül O, Satilmiş T, Bayram F, Göcmen G, Sipahi A, Göker K. Effect of submucosal application of tramadol on postoperative pain after third molar surgery. Head Face Med. 2015;11:35.

86. Martins LD, Rezende M, Loguercio AD, Bortoluzzi MC, Reis A. Analgesic efficacy of ketorolac associated with a tramadol/acetaminophen combination after third molar surgery: a randomized, triple-blind clinical trial. Med Oral Patol Oral Cir Bucal. 2019;24(1):e96-e102.

87. Wynn RL, Bergman SA. Clopidogrel (Plavix): dental considerations of an antiplatelet drug. Gen Dent. 2001;49(6):564-568.

88. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280(21):1837-1842.

89. Huang Q, Rasubala L, Gracely RH, et al. Comparison of analgesic prescriptions for dental pain and patient pain outcomes before vs after an opioid reduction initiative. JAMA Netw Open. 2022;5(8):e2227219.

90. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.Clin Ther. 2003;25(1):81-104.

91. Singh D, Kennedy DH. The use of gabapentin for the treatment of postherpetic neuralgia. Clin Ther. 2003;25(3):852-889.

92. Beal B, Moeller-Bertram T, Schilling JM, Wallace MS. Gabapentin for once-daily treatment of post-herpetic neuralgia: a review. Clin Interv Aging. 2012;7:249-255.

93. Wang J, Zhu Y. Different doses of gabapentin formulations for postherpetic neuralgia: a systematical review and meta-analysis of randomized controlled trials. J Dermatolog Treat. 2017;28(1):65-77.